Literature DB >> 28991824

The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia.

Wei Du1, Dawei Liu, Yun Long, Xiaoting Wang.   

Abstract

BACKGROUND: A vascular waterfall occurs when the critical closing pressure is greater than the mean systemic filling pressure. Because the waterfall phenomenon likely exists in the microcirculation, β1-receptor blockers such as esmolol could have some effect on microcirculation and vascular waterfall.
OBJECTIVES: To determine whether a vascular waterfall exists during septic shock and to assess the effects of vasopressors and β-blockers on vascular waterfall.
DESIGN: Sixteen mongrel dogs were mounted with ultrasonic flow probes to measure renal blood flow. The hemodynamic variables of 16 animals were measured at baseline, after induction of acute endotoxemia; then, they underwent volume expansion, and norepinephrine was used to achieve baseline. After achieving septic myocardial depression, the animals were randomly divided into two groups (esmolol vs control groups) after reaching septic myocardial depression.
MEASUREMENTS AND MAIN RESULTS: There was a pressure gap of 41.9 ± 13.9 mm Hg between the arterial critical closing pressure and the mean systemic filling pressure, indicating that a vascular waterfall was present under baseline conditions. Endotoxemia caused a decrease in cardiac output, mean arterial pressure, and critical closing pressure. Endotoxemia also caused the vascular waterfall to disappear. Neither volume expansion nor norepinephrine had any effect on the vascular waterfall. Esmolol infusion restored the vascular waterfall effect following endotoxemia and resuscitation. The 24-hour survival was 75% in the esmolol group versus 12.5% in controls (p = 0.041).
CONCLUSIONS: Vascular pressure gradients in renal vasculature suggest the presence of a vascular waterfall at baseline. Although this phenomenon disappeared in endotoxemic dogs, it could be restored with β-blocker therapy (esmolol).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28991824     DOI: 10.1097/CCM.0000000000002721

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  The influence of esmolol on right ventricular function in early experimental endotoxic shock.

Authors:  Lex M van Loon; Johannes G van der Hoeven; Peter H Veltink; Joris Lemson
Journal:  Physiol Rep       Date:  2018-09

2.  β-Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure.

Authors:  Lex M van Loon; Gerard A Rongen; Johannes G van der Hoeven; Peter H Veltink; Joris Lemson
Journal:  Physiol Rep       Date:  2019-12

3.  Esmolol response in septic shock patients in relation to vascular waterfall phenomenon measured by critical closure pressure and mean systemic filling pressure: a prospective observational study.

Authors:  Zehan Liu; Chuanliang Pan; Jianping Liu; Hui Liu; Hui Xie
Journal:  J Intensive Care       Date:  2022-01-04

4.  E-Health Ultrasonic Diagnostic Monitoring for Analysis of Cardiac Insufficiency and Neuronal Regulation in Patients with Sepsis in Emergency Department under Image Reconstruction Algorithm.

Authors:  Zhonghua Fang; Mao Zhang
Journal:  Comput Math Methods Med       Date:  2022-01-06       Impact factor: 2.238

5.  Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.

Authors:  Martin Unger; Andrea Morelli; Mervyn Singer; Peter Radermacher; Sebastian Rehberg; Helmut Trimmel; Michael Joannidis; Gottfried Heinz; Vladimír Cerny; Pavel Dostál; Christian Siebers; Fabio Guarracino; Francesca Pratesi; Gianni Biancofiore; Massimo Girardis; Pavla Kadlecova; Olivier Bouvet; Michael Zörer; Barbara Grohmann-Izay; Kurt Krejcy; Christoph Klade; Günther Krumpl
Journal:  Trials       Date:  2018-11-19       Impact factor: 2.279

Review 6.  Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.

Authors:  Yujiro Matsuishi; Bryan J Mathis; Nobutake Shimojo; Satoru Kawano; Yoshiaki Inoue
Journal:  Vasc Health Risk Manag       Date:  2020-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.